Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 75

References for PMC Articles for PubMed (Select 20215131)

1.

Use of oseltamivir after influenza infection is associated with reduced incidence of recurrent adverse cardiovascular outcomes among military health system beneficiaries with prior cardiovascular diseases.

Casscells SW, Granger E, Kress AM, Linton A, Madjid M, Cottrell L.

Circ Cardiovasc Qual Outcomes. 2009 Mar;2(2):108-15. doi: 10.1161/CIRCOUTCOMES.108.820357. Epub 2009 Mar 5.

2.

Viral loads and duration of viral shedding in adult patients hospitalized with influenza.

Lee N, Chan PK, Hui DS, Rainer TH, Wong E, Choi KW, Lui GC, Wong BC, Wong RY, Lam WY, Chu IM, Lai RW, Cockram CS, Sung JJ.

J Infect Dis. 2009 Aug 15;200(4):492-500. doi: 10.1086/600383.

3.

Effects of oseltamivir on influenza-related complications in children with chronic medical conditions.

Piedra PA, Schulman KL, Blumentals WA.

Pediatrics. 2009 Jul;124(1):170-8. doi: 10.1542/peds.2008-0977.

4.
5.

Influenza-associated central nervous system dysfunction in Taiwanese children: clinical characteristics and outcomes with and without administration of oseltamivir.

Huang YC, Li WC, Tsao KC, Huang CG, Chiu CH, Lin TY.

Pediatr Infect Dis J. 2009 Jul;28(7):647-8. doi: 10.1097/INF.0b013e3181986bf9.

PMID:
19483663
6.

Reducing the burden of influenza-associated complications with antiviral therapy.

Ruf BR, Szucs T.

Infection. 2009 Jun;37(3):186-96. doi: 10.1007/s15010-009-8241-1. Epub 2009 May 26. Review.

PMID:
19471854
7.

Incidence of neuropsychiatric adverse events in influenza patients treated with oseltamivir or no antiviral treatment.

Smith JR, Sacks S.

Int J Clin Pract. 2009 Apr;63(4):596-605. doi: 10.1111/j.1742-1241.2009.02010.x.

PMID:
19335705
8.

Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season.

Meijer A, Lackenby A, Hungnes O, Lina B, van-der-Werf S, Schweiger B, Opp M, Paget J, van-de-Kassteele J, Hay A, Zambon M; European Influenza Surveillance Scheme.

Emerg Infect Dis. 2009 Apr;15(4):552-60. doi: 10.3201/eid1504.181280.

9.

Seasonal influenza in adults and children--diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America.

Harper SA, Bradley JS, Englund JA, File TM, Gravenstein S, Hayden FG, McGeer AJ, Neuzil KM, Pavia AT, Tapper ML, Uyeki TM, Zimmerman RK; Expert Panel of the Infectious Diseases Society of America.

Clin Infect Dis. 2009 Apr 15;48(8):1003-32. doi: 10.1086/598513.

10.

Morbidity and mortality associated with nosocomial transmission of oseltamivir-resistant influenza A(H1N1) virus.

Gooskens J, Jonges M, Claas EC, Meijer A, van den Broek PJ, Kroes AM.

JAMA. 2009 Mar 11;301(10):1042-6. doi: 10.1001/jama.2009.297. Epub 2009 Mar 2.

PMID:
19255111
11.

Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States.

Dharan NJ, Gubareva LV, Meyer JJ, Okomo-Adhiambo M, McClinton RC, Marshall SA, St George K, Epperson S, Brammer L, Klimov AI, Bresee JS, Fry AM; Oseltamivir-Resistance Working Group.

JAMA. 2009 Mar 11;301(10):1034-41. doi: 10.1001/jama.2009.294. Epub 2009 Mar 2.

PMID:
19255110
12.
13.

Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007-08.

Hauge SH, Dudman S, Borgen K, Lackenby A, Hungnes O.

Emerg Infect Dis. 2009 Feb;15(2):155-62.

14.

Outcome of influenza infections in outpatients after allogeneic hematopoietic stem cell transplantation.

Khanna N, Steffen I, Studt JD, Schreiber A, Lehmann T, Weisser M, Flückiger U, Gratwohl A, Halter J, Hirsch HH.

Transpl Infect Dis. 2009 Apr;11(2):100-5. doi: 10.1111/j.1399-3062.2008.00362.x. Epub 2009 Jan 20.

PMID:
19175540
15.

Neuraminidase inhibitor resistance after oseltamivir treatment of acute influenza A and B in children.

Stephenson I, Democratis J, Lackenby A, McNally T, Smith J, Pareek M, Ellis J, Bermingham A, Nicholson K, Zambon M.

Clin Infect Dis. 2009 Feb 15;48(4):389-96. doi: 10.1086/596311.

16.

Assessment of neuropsychiatric adverse events in influenza patients treated with oseltamivir: a comprehensive review.

Toovey S, Rayner C, Prinssen E, Chu T, Donner B, Thakrar B, Dutkowski R, Hoffmann G, Breidenbach A, Lindemann L, Carey E, Boak L, Gieschke R, Sacks S, Solsky J, Small I, Reddy D.

Drug Saf. 2008;31(12):1097-114. doi: 10.2165/0002018-200831120-00006. Review.

PMID:
19026027
17.

The influence of oseltamivir treatment on the risk of stroke after influenza infection.

Madjid M, Curkendall S, Blumentals WA.

Cardiology. 2009;113(2):98-107. doi: 10.1159/000172796. Epub 2008 Nov 15.

18.

Low coverage of seasonal influenza vaccination in the elderly in many European countries.

Mereckiene J, Cotter S, Weber JT, Nicoll A, Lévy-Bruhl D, Ferro A, Tridente G, Zanoni G, Berra P, Salmaso S, O'Flanagan D; VENICE Gatekeepers Group.

Euro Surveill. 2008 Oct 9;13(41). pii: 19001. No abstract available.

19.
20.

State-specific influenza vaccination coverage among adults--United States, 2006-07 influenza season.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2008 Sep 26;57(38):1033-9.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk